<--- Back to Details
First PageDocument Content
Science / Drug safety / Design of experiments / Pharmacology / Food and Drug Administration / Institutional review board / Investigational New Drug / Clinical trial / Public Responsibility in Medicine and Research / Clinical research / Research / Medicine
Date: 2012-08-30 13:23:16
Science
Drug safety
Design of experiments
Pharmacology
Food and Drug Administration
Institutional review board
Investigational New Drug
Clinical trial
Public Responsibility in Medicine and Research
Clinical research
Research
Medicine

INSTITUTIONAL REVIEW BOARD FOR THE

Add to Reading List

Source URL: www.upstate.edu

Download Document from Source Website

File Size: 245,13 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document